Personalized Health Project: An Action Summit for LIfe Science Leaders
The Personalized Health Project and video was sponsored by the Ewing Marion Kauffman Foundation.
"Can the wellness movement fuse with the new biology?"
Panel Discussion:
Dean Ornish, MD, Founder and President, Preventative Medicine Research Institute, Clinical Professor of Medicine, UCSF
Sue Seigel, Mohr Davidow Ventures
Paul Billings, MD, PhD, CMO, Life Technologies
Alexandra Drane, President and Co-Founder, Eliza Corporation
Moderator: Thomas Goetz, Executive Editor, Wired Magazine
Solutions
"Playing in the Same Sandbox": David Ewing Duncan
Brief Presentation of a Great Idea, Project or Protocol
Anthony Atala, MD, board member, Regenerative Medicine Foundation; Director, Wake Forest Institute for Regenerative Medicine (by Skype)
An overview of the technologies that will create a personalized health future, Daniel Kraft, MD, Stanford Medical Center and Singularity University
Bio
Anthony Atala
Anthony Atala is Director of the Wake Forest Institute for Regenerative Medicine and Chair of Urology at the Wake Forest University School of Medicine. Dr. Atala is a surgeon, researcher and expert on regenerative medicine and stem cells.
His current work focuses on growing new human cells, tissues and organs (including kidney, blood vessels, cartilage, bladder and pancreas). Ten applications of his technologies have been used clinically. Dr. Atala has received numerous awards, including the Christopher Columbus Foundation Award bestowed on an American working on a discovery that will significantly affect society.
He was named by Scientific American as a Medical Treatments Leader of the Year and by Fast Company as one of 50 people who "will change how we work and live over the next 10 years." He is the editor of numerous journals and books, has published more than 300 journal articles and book chapters, and has applied for or received more than 200 patents.
Paul Billings
Paul Billings, MD, PhD, is CMO of Life Technologies.
Jason Bobe
Jason Bobe serves as the Executive Director of PersonalGenomes.org and Director of Community for the Personal Genome Project based out of George Church's lab at Harvard Medical School. The Personal Genome Project seeks to encourage the thoughtful development of personal genomics technology and practices by building frameworks for prototyping and evaluation at increasing scales.
Jason is co-founder of DIYbio.org, an organization that aims to help make biology a worthwhile pursuit for citizen scientists and amateur biologists. DIYbio is fast becoming the organizational hub for amateur biologists worldwide, uniting the movement's participants through its website, online forums, blog and local chapters.
He has also worked as a Business Development Consultant for OpenWetWare.org, as Director of Business Development at DNA Direct, and as an independent consultant. He has attended both the University of Colorado at Boulder and the Kelley School of Business at Indiana University. He is interested in how emerging biotechnologies and the web are redefining the relationships between scientific research communities, communities from the general public, and the network of actors in-between.
George Church
George Church, PhD is Professor of Genetics, Harvard Medical School, Wyss Institute, Director of the Center for Computational Genetics, Director of the NIH Center for Excellence in Genomic Science (on human genome engineering), founder of PGP and guinea PiG#1. He is a member of the NAS and NAE and Franklin Laureate for Achievement in Science.
Lisa Conte
Lisa Conte, CEO, Napo Pharmaceuticals
Alexandra Drane
Alexandra Drane is the founder and president of the Eliza Corporation. Drane has devoted her career to inspiring people to lead healthier, happier and more engaged lives through the use of innovative technology. Her entrepreneurial spirit and passion for technology and design have led to the launch of four successful healthcare ventures over the past 15 years.
Prior to founding Eliza, Alexandra was a founder of three other healthcare ventures -- all focused on developing products that enable individual behavior change through the use of technology.
She has been named to the Boston Business Journal's "40 Under 40" list and also appears on the Healthspottr Future Health 100 list, which includes some of the most creative and influential people working in healthcare today.
David Ewing Duncan
David Ewing Duncan is an award-winning, best-selling author of six books and numerous essays, articles and short stories, and a television, radio and film producer and correspondent. He is the co-host of NPR's Biotech Nation.
Duncan's most recent book is Experimental Man: What one man’s body reveals about his future, your health, and our toxic world (John Wiley). His last book was Masterminds: Genius, DNA and the Quest to Rewrite Life (Harper Perennial). He also wrote the international bestseller Calendar: Humanity's Epic Struggle to Determine a True and Accurate Year (Harper-Collins/Avon), published in 19 languages, and a bestseller in 14 countries.
Duncan is a Contributing Editor to Wired, and Discover, and a science columnist for the San Francisco Chronicle, a commentator for NPR's Morning Edition and co-host of BioTech Nation on NPR. He has been a special correspondent and producer for ABC's Nightline and 20/20, and a producer for Discovery Television. He is a correspondent for NOVA's ScienceNow!. He is a regular contributor to National Geographic, Fortune and MIT Technology Review, and was a longtime correspondent for Life.
He also writes for Harper's, Atlantic Monthly, Smithsonian, Outside, The Telegraph, The Guardian, The Washington Post Book World, and The New York Times, among others. He contributes to the Dialogues column for Discover.
Sir Richard Feachem
Richard G A Feachem is Professor of Global Health at both the University of California, San Francisco and the University of California, Berkeley, and Director of the Global Health Group at UCSF Global Health Sciences.
He is also a Visiting Professor at London University and an Honorary Professor at the University of Queensland.
James Heywood
James Heywood is the Co-Founder and Chairman of Patients Like Me.
Daniel Kraft
Daniel Kraft, MD, Stanford Medical Center and Singularity University. Kraft is a partner at Proteus Venture Partners.
Fred Lee
Fred Lee, MD, CMO of P4 Institute
Larry Leisure
Larry Leisure, Kleiner Perkins Caufield and Byers
Dean Ornish
Native of Dallas, graduate of UT Austin, Dean earned his M.D. from Baylor and is one of the leading progenitors of the lifestyle-driven approach to the control of chronic diseases like coronary artery disease. Through clinical research studies, he proved that comprehensive lifestyle changes could not only stop the progression of heart disease, but reverse it — and indeed, un-do a great deal of underlying system damage to restore wellness. The author or co-author of more than a dozen books and recipient of numerous major awards and accolades, Dean is a major force in transforming healthcare via patient-centered, integrative approaches.
Sue Siegel
Sue Siegel is a GE Corporate Officer and the CEO of healthymagination, GE's $6 billion global commitment to provide better health for more people by lowering costs and increasing access.
Sue is a 25-year industry leader with corporate and venture capital experience in growing companies that bring key enabling technologies to the forefront of biomedical research and healthcare. Prior to joining GE, she was a General Partner at Mohr Davidow Ventures where she led investments spanning enabling technology platforms, molecular diagnostics and digital health, which leveraged the convergence of these disciplines in driving personalized, consumer-driven and information-based healthcare.
Martyn Smith
Martyn Smith, PhD, School of Public Health, UC Berkeley, The Exposome Project
Michael Stebbins
Michael Stebbins, PhD, Office of Science and Technology Policy, The White House
Massive Health co-founder Aza Raskin discusses how to revolutionize the health industry by engaging elements of design. Feedback loops, Raskin believes, are the secret to behavioral change.
Extent of continuing physical, emotional, mental, and social ability to cope with one's environment. Good health is harder to define than bad health (which can be equated with presence of disease) because it must convey a more positive concept than mere absence of disease, and there is a variable area between health and disease. A person may be in good physical condition but have a cold or be mentally ill. Someone may appear healthy but have a serious condition (e.g., cancer) that is detectable only by physical examination or diagnostic tests or not even by these.
